The administration of orphan nuclear receptor Nurr1 (NR4A2) in a 5xFAD mouse model regulates the AD pathophysiology by reducing Aβ plaque deposition, neuronal loss, microgliosis, and impairment of adult hippocampus neurogenesis [120]. The gene discussed is NR4A2; the disease is Alzheimer disease.